Zentalis Pharmaceuticals (ZNTL) PT Lowered to $4 at Morgan Stanley
Tweet
Share
E-mailGet Alerts ZNTL Hot Sheet
Price: $2.52 -3.45%
Rating Summary:
9 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 15 | New: 50
Rating Summary:
9 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 15 | New: 50
Join SI Premium – FREE
Morgan Stanley analyst Matthew Harrison lowered the price target on Zentalis Pharmaceuticals (NASDAQ: ZNTL) to $4.00 (from $8.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Wells Fargo Assumes Zentalis Pharmaceuticals (ZNTL) at Equal Weight
- UWC BHD (UWC:MK) PT Raised to MYR9.50 at Macquarie
- JPMorgan Downgrades Singapore Exchange (SGX:FP) (SPXCY) to Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
